AYTU: Aytu BioPharma Expected earnings per share growth for next year

Public company logo of aytubio.com (AYTU)

Aytu BioPharma, Inc. (AYTU) relies on ADHD therapy and the pediatric segment, working directly with physicians and patients. This chart of the company's expected EPS growth for the coming year confirms this stability, with the metric holding at 143.10. The diversification of drug distribution rights strengthens the financial foundation, while Adzenys user loyalty, coupled with strict DEA control over production volumes, ensures the resilience of the ecosystem.

Aytu BioPharma Inc (AYTU): Net earnings per share change forecast for next year from 07/04/2022 to 11/16/2026

Analytical breakdowns and data insights for company Aytu Therapeutics (AYTU)

- share price and consensus valuation forecast:
Fundamental company valuation:AYTU, Aytu BioPharma Inc
Finished products of Aytu BioPharma Inc

To build a high-quality portfolio, I rely on market expectations regarding future business performance. This indicator measures the percentage change in projected earnings per share (EPS) for the following year, reflecting the analysts' consensus estimate on net income growth rates. The expansion of insurance coverage for Aytu BioPharma (AYTU) drugs directly impacts the company's forward EPS dynamics model, confirming capitalization potential through sales growth.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PLRX|Applied Therapeutics (APLT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rein Therapeutics Inc (RNTX)|Net earnings per share growth forecast for next year Gelteq Limited|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year